Myths vs facts: CYP1A2 and sleep

The link between CYP1A2 and sleep is often misunderstood. CYP1A2 is an enzyme that primarily metabolizes caffeine. Individuals with a slow variant (e.g., *1F/*1F) break down caffeine more slowly, which can lead to prolonged alertness and potentially poorer sleep quality if caffeine is consumed in the afternoon or evening. However, this is an indirect effect – CYP1A2 does not directly control sleep, but rather influences caffeine sensitivity. A common myth is that a genetic test alone can explain sleep issues. In reality, sleep disturbances are multifactorial (stress, light, hormones). The evidence for using CYP1A2 testing to optimize sleep is weak; no validated clinical recommendations exist. Most studies are mechanistic or based on self-reports. Caution: altering caffeine intake solely based on genotype without considering overall health is not advisable. Focus on sleep hygiene and medical evaluation for persistent problems.